Harvest Fund Management Co. Ltd purchased a new stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 232 shares of the technology company’s stock, valued at approximately $49,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of VEEV. Advisors Asset Management Inc. purchased a new stake in Veeva Systems in the first quarter valued at $28,000. SVB Wealth LLC purchased a new stake in Veeva Systems in the first quarter valued at $227,000. Kennedy Capital Management LLC purchased a new stake in Veeva Systems in the first quarter valued at $941,000. B. Riley Wealth Advisors Inc. lifted its position in Veeva Systems by 118.0% in the first quarter. B. Riley Wealth Advisors Inc. now owns 4,887 shares of the technology company’s stock valued at $1,132,000 after acquiring an additional 2,645 shares during the last quarter. Finally, Tidal Investments LLC raised its holdings in shares of Veeva Systems by 7.5% in the first quarter. Tidal Investments LLC now owns 8,094 shares of the technology company’s stock valued at $1,877,000 after buying an additional 568 shares during the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems Price Performance
VEEV stock opened at $226.76 on Thursday. The company’s 50 day simple moving average is $215.20 and its 200-day simple moving average is $201.66. The firm has a market capitalization of $36.72 billion, a PE ratio of 60.47, a P/E/G ratio of 2.19 and a beta of 0.81. Veeva Systems Inc. has a 12 month low of $165.12 and a 12 month high of $240.68.
Analyst Ratings Changes
VEEV has been the subject of a number of research reports. Barclays upped their target price on shares of Veeva Systems from $240.00 to $260.00 and gave the company an “overweight” rating in a report on Friday, November 8th. Raymond James upped their target price on shares of Veeva Systems from $230.00 to $235.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Royal Bank of Canada upped their target price on shares of Veeva Systems from $250.00 to $275.00 and gave the company an “outperform” rating in a report on Friday, November 8th. UBS Group upped their target price on shares of Veeva Systems from $185.00 to $215.00 and gave the company a “neutral” rating in a report on Monday, August 26th. Finally, BNP Paribas initiated coverage on shares of Veeva Systems in a report on Tuesday, October 8th. They issued an “outperform” rating and a $286.00 target price for the company. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Veeva Systems has an average rating of “Moderate Buy” and an average target price of $236.92.
Read Our Latest Analysis on VEEV
Insider Activity
In related news, insider Thomas D. Schwenger sold 1,126 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $240.01, for a total transaction of $270,251.26. Following the transaction, the insider now owns 27,013 shares of the company’s stock, valued at approximately $6,483,390.13. This represents a 4.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 10.50% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
- Five stocks we like better than Veeva Systems
- Where to Find Earnings Call Transcripts
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Trending Stocks? Trending Stocks Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the FTSE 100 index?
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.